Beta Drugs Limited , one of the leading manufacturers of Oncology medicines in India, proudly announces that it has received approval from the Drug Controller General of India (DCGI) for the launch of Methotrexate Solution for Oral Use.

This approval makes BDL the first company in India to introduce Methotrexate Oral Solution , a patient-friendly and bioequivalent alternative to existing tablet form. The product is indicated for use in acute lymphoblastic leukemia (ALL), lymphomas, various solid tumors, Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA), and Psoriasis Vulgaris including Chronic Plaque Psoriasis, Erythrodermic Psoriasis , Psoriatic Arthritis and Pustular Psoriasis.

Methotrexate is a globally recognized therapy in oncology and autoimmune disorder

See Full Page